Efrat Lelkes, MD, Angira Patel, MD, MPH, Anna Joong, MD, and Jeffrey G. Gossett, MD
Current policy requires separate informed consent for some Public Health Service increased-risk donors, and this can make shared decision making harder.
AMA J Ethics. 2020;22(5):E401-407. doi:
10.1001/amajethics.2020.401.
Dr Stephen P. Richmond joins Ethics Talk to discuss his article, coauthored with Dr Vanessa Grubbs: “How Abolition of Race-Based Medicine Is Necessary to American Health Justice.”
Dr Jing Li joins Ethics Talk to discuss her article, coauthored with Dr Robert Tyler Braun, Sophia Kakarala, and Dr Holly G. Prigerson: “How Should Cost-Informed Goals of Care Decisions Be Facilitated at Life’s End?”
Annika Brakebill, A. Mark Fendrick, MD, and Jeffrey T. Kullgren, MD, MS, MPH
These key steps are ones health sector stakeholders should take to help patients and clinicians use pricing information to inform health decision making.
AMA J Ethics. 2022;24(11):E1034-1039. doi:
10.1001/amajethics.2022.1034.
Shelley Wall, MBChB, Nikki Allorto, MBChB, Ross Weale, MBBS, Victor Kong, PhD, and Damian Clarke, PhD
Caring for severe burn injuries in low- and middle-income countries requires making decisions about resource allocation given particular contextual factors.
AMA J Ethics. 2018;20(6):575-580. doi:
10.1001/journalofethics.2018.20.6.msoc1-1806.
Sandra R. DiBrito, MD and Macey L. Henderson, JD, PhD
Organ donor potential should not be considered during active resuscitation of trauma patients, and trauma surgeons should not make organ donation requests.
AMA J Ethics. 2018;20(5):447-454. doi:
10.1001/journalofethics.2018.20.5.ecas4-1805.
Although identical twin-to-twin skin grafting has resulted in excellent survival rates in burn patients, the nature and scope of ethical decision making in monozygotic sibling skin grafting needs further examination.
AMA J Ethics. 2018;20(6):537-545. doi:
10.1001/journalofethics.2018.20.6.cscm2-1806.
Consideration of what constitutes sufficient information about how donation protocols can interfere with a patient’s dying process is a key feature of consent processes.
AMA J Ethics. 2018;20(8):E708-716. doi:
10.1001/amajethics.2018.708.
Targeted dosing to treat pediatric inflammatory bowel disease is challenging because dosing guidelines are based on data gathered from adult subjects of clinical trials. Patients’ families and health care organizations also incur high costs and must try to balance potential benefits against risks of ongoing monitoring.
AMA J Ethics. 2018;20(9):E841-848. doi:
10.1001/amajethics.2018.841.